Which TIBSOVO (ivosidenib) clinical trials are recruiting or active right now?
I can’t tell which specific TIBSOVO trials are currently open without a live clinical-trials database (the provided information here doesn’t include any current trial listings). If you share whether you mean:
- TIBSOVO for newly diagnosed or relapsed AML, or
- TIBSOVO in other cancers (it’s most known for IDH1-mutated AML),
…I can narrow the search terms and the trial phases/regimens to look for.
Where to find the most up-to-date trial status for tibsovo
The fastest way to see “current” trials (recruiting, active not recruiting, enrolling by invitation, locations, and trial IDs) is to search:
- ClinicalTrials.gov for “ivosidenib” and then filter by disease, phase, and status.
- If you want, tell me your country/region, and I’ll suggest the exact filters to apply (for example: recruiting only, distance from your ZIP, phase 1–3).
What trial types commonly include TIBSOVO
TIBSOVO trials often involve IDH1-mutated cancers and frequently test it:
- as monotherapy vs in combination (for example, with hypomethylating agents or chemotherapy in AML),
- in specific mutation-defined AML populations,
- in newer lines of therapy (relapsed/refractory or post-transplant settings, depending on the study).
If you want, I can list trials you care about—what details should you provide?
Reply with:
1) Disease (AML? MDS? another indication?)
2) Setting (newly diagnosed vs relapsed/refractory)
3) Your country (or ZIP/postcode)
4) Preferred trial phase (I, II, III) and whether you want recruiting only
Then I can help you find the most relevant active/recruiting TIBSOVO studies and what to look for in each.
Source